115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transient state change, but not permanent subtype change, after HER2-targeted therapy for HER2-positive breast cancer
    Meeting Abstract

    Tanioka, M.; Parker, J. S.; Henry, L. N.; Tolaney, S.; Dang, C.; Krop, I. E.; Harris, L.; Polley, M.; Berry, D. A.; Winer, E. P.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analyses
    Meeting Abstract

    Tamura, K.; Modi, S.; Tsurutani, J.; Takahashi, S.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice
    Meeting Abstract

    Saverno, K. R.; Carter, G. C.; Li, L.; Battiato, L. A.; Huang, Y. J.; Smyth, E. N.; Price, G. L.; Sheffield, K. M.; Baxi, S. S.; Kuk, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Primary and secondary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)
    Meeting Abstract

    Pernas, S.; Villagrasa, P.; Nuciforo, P. G.; Vivancos, A.; Scaltriti, M.; Rodon, J.; Burgues, O.; Canes, J.; Duenas, M.; Cecchi, F.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K.; Grkovski, M.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A. D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment of metastasis (TMEM) score in residual breast carcinoma post-neoadjuvant chemotherapy as an independent prognosticator of distant recurrence
    Meeting Abstract

    Oktay, M. H.; D'Alfonso, T.; Ginter, P.; Lanjewar, S.; Entenberg, D.; Pastoriza, J. M.; Wang, Y.; Lin, Y.; Karagiannnis, G. S.; Lin, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Recurrent but not pathognomonic fusion genes in mucinous carcinomas of the breast
    Meeting Abstract

    Pareja, F.; Gularte-Merida, R.; Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Piscuoglio, S.; Marchio, C.; Vincent-Salomon, A.; Brogi, E.; Weigelt, B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Metaplastic breast carcinomas and uterine carcinosarcomas are histologically and genetically related
    Meeting Abstract

    Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Smith, E.; Pareja, F.; Papanastasiou, A. D.; Fusco, N.; Marchio, C.; Brogi, E.; Wen, H. Y.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
    Meeting Abstract

    Liu, Y. L.; Bager, C. L.; Willumsen, N.; Kornhauser, N.; Cobham, M.; Andreopoulou, E.; Cigler, T.; Moore, A.; LaPolla, D.; Fitzpatrick, V.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save